Dr. Rahul Aggarwal graduated from the Northwestern University Feinberg School of Medicine. He did both his residency in internal medicine and his fellowship in hematology/oncology at the UCSF. He is board certified in the field of hematology, internal medicine, and medical oncology. As a medical oncologist, he is specialized in the treatment of cancer affecting the lungs, larynx, and ovary as well as mesothelioma. With around a decade of clinical experience, he is currently affiliated with the UCSF Medical Center. Dr. Aggarwal has also contributed to six research papers.
Northwestern University Feinberg
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma.
Thomas, S.,Aggarwal, R.,Jahan, T.,Ryan, C.,Troung, T.,Moore Cripps, A.,Raha, P.,Thurn, K. T.,Chen, S.,Grabowsky, J. A.,Park, J.,Hwang, J.,Daud, A.,Munster, P. N.; Ann. Oncol.. 2016 Feb 24.See more >>
First-in-human Phase I Study of GSK2126458, an Oral Pan-Class I Phosphatidylinositol-3-kinase inhibitor, in Patients with Advanced Solid Tumor Malignancies.
Munster, P. N.,Aggarwal, R.,Hong, D.,Schellens, J. H.,van der Noll, R.,Specht, J.,Witteveen, P. O.,Werner, T.,Dees, E. C.,Bergsland, E. K.,Agarwal, N.,Kleha, J. F.,Dur...; Clin. Cancer Res.. 2015 Nov 26.See more >>
Somatostatin Imaging of Neuroendocrine-Differentiated Prostate Cancer.
Hope, T. A.,Aggarwal, R.,Simko, J. P.,VanBrocklin, H. F.,Ryan, C. J.; Clin Nucl Med. 2015 Mar 19.See more >>